Research ArticleRheumatoid Arthritis
Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
Anat Fisher, Marie Hudson, Robert W. Platt and Colin R. Dormuth for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
The Journal of Rheumatology January 2021, 48 (1) 16-24; DOI: https://doi.org/10.3899/jrheum.191252
Anat Fisher
1A. Fisher, Research Associate, MD, PhD, C.R. Dormuth, Associate Professor, ScD, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia;
Marie Hudson
2M. Hudson, Associate Professor, MD, Division of Rheumatology, Jewish General Hospital and Lady Davis Institute, Department of Medicine, McGill University, Montreal, Québec;
Robert W. Platt
3R.W. Platt, Professor, PhD, Departments of Pediatrics and of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Colin R. Dormuth
1A. Fisher, Research Associate, MD, PhD, C.R. Dormuth, Associate Professor, ScD, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia;
In this issue
The Journal of Rheumatology
Vol. 48, Issue 1
1 Jan 2021
Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
Anat Fisher, Marie Hudson, Robert W. Platt, Colin R. Dormuth
The Journal of Rheumatology Jan 2021, 48 (1) 16-24; DOI: 10.3899/jrheum.191252